arrow
K

Koutaro Yokote

chiba university
H指数:60
被引数:2.2万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Little Evidence of Atherosclerosis in a Middle-Aged Japanese Woman with Familial Hypercholesterolemia Carrying PCSK9 (p.Glu32Lys) and ABCG8 (p.Ile419Asn) Variants Despite Elevated Lipoprotein(a) Levels

一名患有家族性高胆固醇血症的中年日本女性,尽管载脂蛋白(a)水平升高,但携带PCSK9 (p.Glu32Lys)和ABCG8 (p.Ile419Asn)变异,其动脉粥样硬化证据较少。

2025-12-010
PRE
Hypoxia, iron, and ferroptosis: a novel perspective on pheochromocytoma progression and therapy

缺氧、铁和 ferroptosis:对嗜铬细胞瘤进展和治疗的全新视角

2025-12-010
PRE
PS13.4: Autologous transplantation of LCAT gene-transduced adipocytes enabled long-term LCAT replacement in a patient with LCAT deficiency in first in human clinical trial.

PS13.4: 自体转导LCAT基因的脂肪细胞移植使得在首个人类临床试验中,一名LCAT缺乏症患者实现了长期LCAT替代。

2025-10-200
PRE
Redox-dependent liver gluconeogenesis impacts different intensity exercise in mice

氧化还原依赖性肝脏糖异生影响不同强度运动在小鼠中的表现

2025-09-180
OAAI
Emerging strategies, applications and challenges of targeting NAD+ in the clinic

张 J, 王H-L, Lautrup S, Nilsen HL, Treebak JT, Watne LO, 等. 靶向NAD+的临床新兴策略、应用与挑战。Nat Aging. (2025). doi: 10.1038/s43587-025-00947-6

2025-09-090
PRE
Sodium-glucose co-transporter 2 inhibitors reduce the intravitreal anti-VEGF treatment necessity in eyes with early diabetic macular oedema: A post-hoc analysis focusing on the fellow eye of the COMET trial

Sodium-glucose co-transporter 2抑制剂可降低早期糖尿病黄斑水肿患眼对玻璃体内抗-VEGF治疗的需求:一项关注COMET试验对侧眼的回顾性分析

2025-08-040
PRE